Evidence map›Paper›PMID 29117564›Full record

ArticleCell reports2017

An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.

Aaron F Carlin, Emily M Plummer, Edward A Vizcarra, Nicholas Sheets, Yunichel Joo, William Tang, Jeremy Day, Jay Greenbaum, Christopher K Glass, Michael S Diamond and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Transcriptomics of early responses to purifiedFrontiers in immunology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Aaron F CarlinDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Emily M PlummerDivision of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
Edward A VizcarraDivision of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
Nicholas SheetsDivision of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
Yunichel JooDivision of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
William TangDivision of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
Jeremy DayDivision of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
Jay GreenbaumDivision of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA.
Christopher K GlassDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA; Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
Michael S DiamondDepartments of Medicine, Pathology and Immunology, and Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Sujan ShrestaDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA; Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, USA. Electronic address: sujan@lji.org.
La Jolla Institute for Immunology · USUniversity of California, San Diego · USWashington University in St. Louis · US

Funding

UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
IRF-3/5/7-Independent Antiviral ImmunityR01AI116813 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SHRESTA, SUJAN · 2016 to 2019
$1.9M
Mucosal Vaccination Against Dengue Virus InfectionU01AI082185 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI LO, DAVID D, SHRESTA, SUJAN · 2009 to 2010
$1.8M
NCATS NIH HHS KL2 TR001444NIAID NIH HHS R01 AI116813NIAID NIH HHS U01 AI082185
6 · The paper itself

Abstract

Interferon-regulatory factors (IRFs) are a family of transcription factors (TFs) that translate viral recognition into antiviral responses, including type I interferon (IFN) production. Dengue virus (DENV) and other clinically important flaviviruses are suppressed by type I IFN. While mice lacking the type I IFN receptor (Ifnar1

Indexed as

Drug Resistance, ViralAnimalsAntibodiesAntiviral AgentsCells, CulturedDengueDengue VirusDown-RegulationInterferon-gammaInterferon Regulatory Factor-1Interferon Regulatory FactorsInterferon Type IMiceMice, Inbred C57BLMice, KnockoutReceptor, Interferon alpha-betaAntibodiesAntiviral AgentsIfnar1 protein, mouseInterferon-gammaInterferon Regulatory Factor-1Interferon Regulatory FactorsInterferon Type IIrf1 protein, mouseReceptor, Interferon alpha-betadengueflavivirusIFNsIL-12innate immunityinterferonIRF-1IRFsmacrophagesmouse models

Identifiers

PMID29117564
PMCPMC5696617
OpenAlexW2767579715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.